The Joint

OverviewSuggest Edit

The Joint is reinventing chiropractic care by making quality healthcare affordable for patients seeking pain relief and ongoing wellness. Its network consists of modern, consumer friendly chiropractic clinics and individually selected Doctors of Chiropractic that deliver quality pain relief and preventative care to the highest standards. The Company's membership plans are designed to make chiropractic care accessible, and its no-insurance-necessary approach to chiropractic care is revolutionizing the way people receive health care - putting the relationship back where it belongs, between people and their doctors. 

TypePublic
Founded1999
HQScottsdale, USMap
Websitethejoint.com
Employee Ratings3.6More
View Jobs (282)

Recent NewsAll News

Latest Updates

Employees (est.) (Mar 2019)138(-6%)
Job Openings282
Revenue (FY, 2017)$25.2 M(+23%)
Share Price (Dec 2019)$18.7 (-2%)

Key People/Management at The Joint

Peter D. Holt

Peter D. Holt

President, Interim Principal Financial Officer & Chief Executive Officer
Jorge Armenteros

Jorge Armenteros

Vice President of Operations
Jason Greenwood

Jason Greenwood

Vice President of Marketing
Amy Karroum

Amy Karroum

Vice President of Human Resources
Eric Simon

Eric Simon

Vice President of Franchise Sales & Development
Manjula Sriram

Manjula Sriram

Vice President of Information Technology
Show more

The Joint Office Locations

The Joint has an office in Scottsdale
Scottsdale, US (HQ)
16767 N Perimeter Dr #240
Show all (1)

The Joint Financials and Metrics

The Joint Revenue

The Joint's revenue was reported to be $25.16 m in FY, 2017 which is a 22.6% increase from the previous period.
USD

Revenue (Q3, 2019)

12.7m

Gross profit (Q3, 2019)

11.3m

Gross profit margin (Q3, 2019), %

88.8%

Net income (Q3, 2019)

617.0k

EBIT (Q3, 2019)

640.4k

Market capitalization (2-Dec-2019)

259.0m

Closing stock price (2-Dec-2019)

18.7

Cash (30-Sept-2019)

7.8m

EV

264.0m
The Joint's current market capitalization is $259 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

7.1m13.8m20.5m25.2m

Revenue growth, %

94%48%23%

Cost of goods sold

2.2m2.8m2.9m3.3m

Gross profit

4.9m11.0m17.6m21.9m
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2019Q3, 2019

Revenue

1.8m2.5m3.4m4.1m4.3m5.0m5.5m5.7m6.0m6.5m11.2m12.7m

Cost of goods sold

585.8k545.3k791.8k745.5k740.0k727.7k718.8k742.1k770.2k819.2k1.3m1.4m

Gross profit

1.2m2.0m2.6m3.4m3.5m4.2m4.8m4.9m5.2m5.7m9.9m11.3m

Gross profit Margin, %

68%78%77%82%83%85%87%87%87%87%88%89%
show all
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

20.8m16.8m3.0m4.2m8.7m

Accounts Receivable

704.9k743.2k1.0m1.1m1.2m

Prepaid Expenses

542.3k882.0k

Inventories

375.9k366.0k499.5k
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

2.4m17.1m12.6m9.5m10.4m6.1m3.4m2.7m3.0m2.6m4.0m4.6m5.6m8.1m9.5m7.8m

Accounts Receivable

333.2k775.7k458.9k605.9k1.6m1.8m1.9m1.2m1.1m1.3m1.0m1.2m1.2m1.1m1.0m1.3m

Prepaid Expenses

69.0k80.3k97.2k151.8k445.0k359.7k891.9k893.5k557.2k604.8k733.5k702.2k830.6k887.7k1.1m

Current Assets

5.5m19.5m14.5m11.6m13.6m9.5m7.4m5.8m5.6m5.4m6.6m7.2m8.4m10.9m12.4m11.3m
show all
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(3.0m)(8.8m)(15.2m)(3.3m)253.1k

Depreciation and Amortization

210.1k1.3m2.6m2.0m1.6m

Inventories

(352.2k)9.9k(133.5k)

Accounts Payable

1.0m(291.5k)(953.1k)(36.8k)63.6k
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

(464.0k)(1.9m)(3.8m)(5.4m)(3.5m)(6.8m)(9.4m)(1.6m)(2.7m)(3.1m)(386.9k)(429.7k)(581.5k)952.6k1.4m2.0m

Depreciation and Amortization

141.7k122.6k401.1k822.5k575.5k1.2m1.9m578.0k1.1m1.6m387.4k792.4k1.2m365.7k770.1k1.3m

Accounts Payable

450.5k304.2k180.7k164.9k(1.2m)(1.1m)(1.2m)34.2k(83.6k)(336.5k)(133.0k)(384.5k)(225.8k)(276.1k)(154.5k)223.2k

Cash From Operating Activities

(114.4k)(1.3m)(2.5m)(4.0m)(5.8m)(8.1m)(10.3m)(1.3m)(734.7k)(1.4m)(33.1k)613.2k1.9m459.5k2.8m4.7m
show all
USDY, 2019

EV/EBIT

412.2 x

EV/CFO

56.1 x

Financial Leverage

11 x
Show all financial metrics

The Joint Operating Metrics

FY, 2014FY, 2015FY, 2016

Clinics

246 312 370

Patient Visits

2.17 m3.20 m4.10 m
Show all operating metrics

The Joint Revenue Breakdown

Embed Graph

The Joint revenue breakdown by business segment: 41.7% from Corporate Clinics and 58.3% from Franchise Operations

The Joint Online and Social Media Presence

The Joint's Trends

Embed Graph

The Joint News and Updates

November 21, 2019

The Joint Chiropractic Reaches Milestone: Opening of 500th Clinic

SCOTTSDALE, Ariz., Nov. 21, 2019 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, has reached a remarkable milestone – the opening of its 500th chiropractic clinic. Since its founding in Tucson,...
November 21, 2019

New book from The Joint Commission and Joint Commission Resources offers checklists to keep health care workers safe

The straightforward and easy-to-use checklists were created by JCR using Joint Commission standards, as well as authoritative guidelines from the Occupational Safety and Health Administration (OSHA), National Institute for Occupational Safety and Health (NIOSH) and Centers for Disease Control and Pr…
October 01, 2019

The Joint Chiropractic Unveils New Brand Campaign

SCOTTSDALE, Ariz., Oct. 1, 2019 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced a new brand campaign focusing on pain relief and highlighting real patients, as well as their chiropractic...
September 23, 2019

First Data On Combination Of Enlivex’s Allocetra-OTS Immunotherapy and CAR-T Therapy Designed For Treating Solid Tumors Revealed At The Joint IIS-ISCR Special 2019 Conference

Nes-Ziona, Israel, Sept. 23, 2019 (GLOBE NEWSWIRE) --  Enlivex Therapeutics Ltd. (Nasdaq:ENLV), a clinical-stage immunotherapy company, today announced the first presentation of its preclinical studies, which were designed to evaluate the combination of Enlivex’s Allocetra-OTS immunotherapy and CA…
September 19, 2019

The Joint Corp. to Present at the 5th Annual B. Riley FBR Consumer & Media Conference

SCOTTSDALE, Ariz., Sept. 19, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will present at the 5th Annual B. Riley FBR Consumer & Media Conference on Thursday, October 3, 2019 at the Sofitel Hotel in N…
August 22, 2019

The Joint Chiropractic is the Official Chiropractor for Georgia Tech Athletics

SCOTTSDALE, Ariz., Aug. 22, 2019 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's leading chiropractic franchise, is proud to announce it is the official chiropractor for Georgia Tech Athletics for the 2019-2020 Academic Year. This partnership reflects the strong relationship...
Show more

 The Joint Frequently Asked Questions

  • When was The Joint founded?

    The Joint was founded in 1999.

  • Who are The Joint key executives?

    The Joint's key executives are Peter D. Holt, Jorge Armenteros and Jason Greenwood.

  • How many employees does The Joint have?

    The Joint has 138 employees.

  • Who are The Joint competitors?

    Competitors of The Joint include Wellframe, OneTaste and SCIO Health Analytics.

  • Where is The Joint headquarters?

    The Joint headquarters is located at 16767 N Perimeter Dr #240, Scottsdale.

  • Where are The Joint offices?

    The Joint has an office in Scottsdale.

  • How many offices does The Joint have?

    The Joint has 1 office.